In order to establish MIATA as a broadly accepted framework for reporting data from human T cell immune assays to scientific journals and to reach our long-term goals, many steps are necessary.

WHAT HAS BEEN ACHIEVED SO FAR?

The MIATA Core Team was constituted and drafted a first document (Version 0) of MIATA. The project was officially announced in Immunity and the MIAT A website was launched (both in October 2009). The scientific community was invited to comment on the proposed framework (Modules 1-5; version 0). The MIATA core team conducted a first consensus workshop together with invited panelists representing different areas of immunology on March 19, 2010. During the workshop and webinars the comments from the public consultation period were discussed.

ONGOING ACTIVITIES?

This workshop is now being supplemented by three webinars conducted in May 2010. The revised version 1 of MIATA modules 1-5 will be made available on this web site by the end of May 2010. 

NEXT STEPS AND PERSPECTIVES?

All colleagues in the field are again invited to actively contribute to shaping the MIATA modules. We are aiming at another intensive vetting process which is expected to further refine the current MIATA modules and increase the acceptability of the MIATA concept. The MIATA Core Team members will continue to present the concept to individuals, associations and editors. Once the vetting process has frozen and the document has been fully matured (Version 2) we are planning to publish MIATA in a scientific journal. Based on the success of the MIATA for scientific publications, the project is envisioned to enter into a second phase, and might secure funding to establish an openly accessible database and a corresponding reporting framework to fill this database and enable data mining and meta-analysis.    

Any input to the document is highly welcome and can be submitted via  This e-mail address is being protected from spambots. You need JavaScript enabled to view it . We will continue to transparently list all contributions and comments. 

.